New non-executive director at Cell Medica
This article was originally published in Scrip
Executive Summary
Cell Medica, a UK-based cellular therapeutics company focused on the development, manufacture and marketing of cellular immunotherapy products to treat infectious diseases and cancer, has appointed Dr Thomas Hecht non-executive director. Dr Hecht is chairman of Cytos Biotechnology, chairman of Delenex Therapeutics and also chairs the board of Affimed Therapeutics and the advisory council of SuppreMol. He has also worked for Amgen and ESBATech.